RRS HYALIFT 75 PROACTIVE 6X5ML

RRS HYALIFT 75 PROACTIVE 6X5ML is a solution:
- Biorevitalising and moisturising for the skin.
- Effective on mature skin.
- With tensor effect.

- SKIN TECH PHARMA GROUP S.L.U.
- NAME: RRS HYALIFT 75 PROACTIVE 6X5ML
- COMPOSITION: Non-cross-linked hyaluronic acid 75 mg/5 ml, 16 amino acids, 5 polyphenols, 6 antioxidants.
- PRESENTATION: 6 x 5 ml.
- INDICATIONS: Intensive bio-revititalising treatment indicated for the prevention and treatment of photo- and chronological skin ageing.
- INJECTION DEPTH: Superficial or medium-superficial intradermal injection.
- DURATION: For optimal results, 6 initial treatments are recommended. Sessions can be repeated once a week. To maintain the effect over time, maintenance treatments can be carried out every 4 months.
- USE: Strict medical use.

- Vials: 6 x 5 ml.

Face, neck, décolleté and hands.

Non-cross-linked hyaluronic acid 75 mg/5 ml, 16 amino acids, 5 polyphenols, 6 antioxidants.

- The product should only be used by a doctor or qualified health care personnel experienced in mesotherapy and intradermal injection techniques.
- Strictly apply aseptic technique to reduce the risk of local infection.
- Do not use the product if the packaging is opened, damaged or past its expiry date.
- The device is for single use only: do not re-use or attempt re-sterilisation.
- Inject into the superficial or mid-dermal plane, according to recommended techniques and after clinical evaluation of the patient.
- Inform the patient of the possible occurrence of transient local reactions (reddening, oedema, swelling, mild pain or small haematomas), usually of short duration.
- After treatment, avoid intense sun exposure, UV lamps, saunas, steam baths and intense physical activity for at least 24-48 hours.
- Use caution in patients with an allergic history or particularly sensitive skin.

RRS HYALIFT 75 PROACTIVE 6X5ML is contraindicated in the following cases:
- Known or suspected hypersensitivity to hyaluronic acid or any of the components of the formulation.
- Presence of active skin infection, inflammation, dermatitis, open lesions or skin changes in the area to be treated.
- Patients with active autoimmune diseases or conditions that significantly alter the immune response.
- Patients on inadequately controlled systemic immunosuppressive or cortisone therapy.
- Pregnancy and lactation, in the absence of sufficient clinical data on product safety.
- Patients under 18 years of age.

Deeply moisturises the skin and provides lasting revitalisation. Improves the appearance of the skin and gives it a radiant, youthful appearance.